All posts by imreal

Draper Advances Growth-Adaptive Pediatric Heart Valve with Sutureless Adhesive


Draper engineers are developing the Low-force Expanding/Adaptable Pediatric (LEAP) Valve—the first heart valve that can grow with the patient. Credit: Draper

“Draper is helping children, families and physicians through the development of the passively expanding LEAP Valve which would reduce the number of surgeries needed for 0-to-6-year-old children born with defects,” said Corin Williams, Draper’s principal investigator of the LEAP heart valve.

Babies born with heart valve defects will have as many as 3 to 5 open heart surgeries before adulthood to replace prosthetics as they grow. Mortality and morbidity remain high, in part because there is no clinical standard for valve replacement in children under 5 years of age.

Eliminating even one of these surgeries would relieve these patients and their families of the health risk, stress and financial burden of a hospital stay and recovery. To address this need, Draper engineers are developing the Low-force Expanding/Adaptable Pediatric (LEAP) Valve—the first heart valve that can grow with the patient.

The LEAP™ Valve features a stent that can expand from 7 mm to 14 mm in diameter—making it ideal for infants through children up to 5 to 6 years old. As the patient grows, the device expands passively, applying a low outward force—much like a spring—eliminating the need for a balloon catheter or other invasive methods to mechanically expand the device.

“Draper is helping children, families and physicians through the development of the passively expanding LEAP Valve which would reduce the number of surgeries needed for 0-to-6-year-old children born with defects,” said Corin Williams, senior member of Draper’s Technical Staff and principal investigator of the LEAP heart valve.

Preclinical studies of the LEAP Valve are currently underway at Boston Children’s Hospital and Seattle Children’s Hospital.

Recently, Williams and her team developed an alternative to suturing the device to a bioprosthetic valve. The “sutureless” alternative, known as MANTIS (Mechanical Adhesion to Tissue), relies on microstructures for mechanical integration. Current practices require suturing by hand, which is both time-consuming and expensive when trying to construct smaller devices. MANTIS will allow faster and less labor-intensive device manufacturing.

In developing MANTIS, Draper turned for inspiration to its work on DARPA’s Z-Man program. For Z-Man, Draper developed a reversible adhesive elastomer material called MicroHold as part of a system that allows humans to climb glass walls.

Daniel King, senior member of Draper’s Technical Staff and a member of the LEAP Valve team, explains: “MANTIS builds upon principles of manufacturing microstructures that were first developed for the MicroHold material. The LEAP heart valve will incorporate the microstructures we are developing to integrate mechanically with the bioprosthetic valve tissue without the need for sutures.”

The MANTIS technology may have other applications, including hemorrhage control. “Additional development of MANTIS could open the door to a range of potential use cases, including external wound closure, sealing of internal organ lacerations and anastomosis, a procedure that involves connecting vessels and similar parts of the body,” King added.

Williams said the next major step for the LEAP Valve will be an Investigational Device Exemption submission to the FDA for first-in-human early feasibility studies. “Our goal is approval via the Humanitarian Device Exemption Pathway, with initial use in the lower risk pulmonary valve position, and eventual application to all 4 valve positions.”

Initially funded internally, the LEAP Valve won recognition for innovation and a prestigious FDA P50 grant from the Children’s National Health System. It was also recognized by the American Society for Artificial Internal Organs and the Pediatric Device Innovation Symposium. Recently, the LEAP Valve was named a 2022 Peer Reviewed Medical Research Highlights by the Department of Defense’s Congressionally Directed Medical Research Programs.

This work was supported by the U.S. Army Medical Research Acquisition Activity, through the program “Growth-Adaptive Pediatric Heart Valves: Addressing a Critical Unmet Need for Infants and Young Children That Saves Lives and Reduces Surgeries” under award number W81XWH2010295. Opinions, interpretations, conclusions and recommendations are those of the author and are not necessarily endorsed by the Department of Defense.

In conducting research using animals, the investigators adhere to the laws of the United States and regulations of the Department of Agriculture.

The U.S. Army Medical Research Acquisition Activity, 820 Chandler Street, Fort Detrick MD 21702-5014 is the awarding and administering acquisition office.

Draper

At Draper, we believe exciting things happen when new capabilities are imagined and created. Whether formulating a concept and developing each component to achieve a field-ready prototype or combining existing technologies in new ways, Draper engineers apply multidisciplinary approaches that deliver new capabilities to customers. As a nonprofit engineering innovation company, Draper focuses on the design, development and deployment of advanced technological solutions for the world’s most challenging and important problems. We provide engineering solutions directly to government, industry and academia; work on teams as prime contractor or subcontractor; and participate as a collaborator in consortia. We provide unbiased assessments of technology or systems designed or recommended by other organizations—custom designed, as well as commercial-off-the-shelf. Visit Draper at http://www.draper.com.

Share article on social media or email:

NANISX LLC To Focus On ASC Spine Surgeries Hires Ex-Medtronic David Flickinger MBA As New CEO


David Flickinger CEO of NANISX LLC, a KICVentures Group Spine Company

We are driven to build NANISX as the leading ASC spine company that develops world-class products plus delivers an unmatched physician to physician education experience

Effective September 15, 2022 NANISX LLC, a spine medical device company excelling in developing less exposure surgery (LES) technologies in spine surgeries for ambulatory surgery centers (ASC) has announced that the firm has appointed former Medtronic, and Nuvasive sales executive, David Flickinger MBA as their new Chief Executive Officer (CEO).

“I couldn’t be more excited about the opportunity to build on the legacy and leadership of these KICVentures Group portfolio companies, NanoFuse Biologics, InSpan and Sacrix, now combined to be known as NANISX LLC. As an ever-greater number of spine procedures transition to the outpatient setting, we are among the first to focus our cutting-edge techniques and technologies for the ASC ecosystem to lead in improving less invasive care for patients. I’m looking forward to bringing the leadership and commercial expertise required for these therapies to reach their full potential.”

We’re looking to build out a team that shares both our vision and urgency to rapidly scale and execute on this incredible opportunity to improve patient lives. We are driven to build NANISX as the leading ASC spine company that develops world-class products plus delivers an unmatched physician to physician education experience which empowers rapid adoption of safe, effective, and highly reproducible procedures with great outcomes.

About David Flickinger

Mr. Flickinger has been in leadership positions at public companies such as Medtronic (MDT), Nuvasive (NUVA) and has held numerous sales leadership roles at Surgalign (SRGA) since its formation in 2020. He has proven experience in the spine and orthobiologics industry with influence on the buy and sell side of strategic mergers and acquisitions, management, development and deployment of strategic opportunities, the formation of distributor alliances and commercializing Coflex interspinous device and other innovative medical devices to the spine market.

Prior to a career in healthcare, David was an Infantry Officer in the United States Marine Corps, where he served as a Platoon Commander and Company Executive Officer with 3d Battalion 1st Marine Division. David was also the co-founder of Doc Social, a physician education and social media platform launched in December of 2020.

Watch David Flickinger MBA NANISX new CEO Introduction and Q&A Video

INVESTORS

Series A Now open in KICVentures Group.

With a revenue and EBITDA positive position from which to start, we are well-positioned to create tremendous value for investors, especially as we prepare for an IPO.

INVESTOR@kicventures.com.

About NANISX LLC

NANISX LLC is privately owned by the KICVentures Group and is a spine medical device company excelling in developing less exposure surgery (LES) technologies in spine surgeries for ambulatory surgery centers (ASC). NANISX is formed from the merger of NanoFUSE Biologics LLC, Inspan LLC and Sacrix LLC. NANISX cross markets to Interventional Pain Management (IPM), Orthopedic spine surgeons and Neurosurgeons under NANISX Pain division and NANISX Ortho-Neuro division.

About NanoFUSE Biologics LLC

NanoFUSE Biologics LLC is privately owned by the KICVentures Group and has a proprietary fiber-based synthetic bioactive glass. NanoFUSE is the only FDA-approved combination of bioactive glass plus DBM and is proven for regenerating bone.

About InSpan LLC

InSpan LLC is privately owned by the KICVentures Group and is focused on advancing the platform of patented interspinous interlaminar fixation technology. The InSpan device has a proven ten-year track record with thousands implanted since FDA clearance in 2010. There are no documented device-related failures or spinous process fractures that have plagued other competitive ISP devices.

About Sacrix LLC

Sacrix LLC is privately owned by the KICVentures Group and is focused on revolutionary percutaneous fluoroscopic lateral-oblique sacroiliac joint fusion technologies for the treatment of sacroiliac dysfunction and sacroiliitis. Sacrix developed its patented Sacrofuse threaded implant to be inserted percutaneously and received FDA clearance in 2015. The Gen1 Sacrofuse implant was compared head-to-head with market leader SI bone (SIBN) and found to have a 400% increase in pull-out strength. Sacrix has trained over 200 physicians to perform its revolutionary percutaneous lateral-oblique sacroiliac joint fusion technique safely and effectively through a 1.5 cm incision minimally invasively in outpatient ambulatory surgery centers.

About KICVentures Group

Founded in 2000 makes us the most experienced healthcare investment holding company with the largest portfolio of medical device technologies focused on solutions for less invasive outpatient spine surgery. Our investment strategy is to acquire or invent disruptive technologies using our own capital or partner with private individual investors. This allows us the freedom to make quick and nimble decisions such as when we acquired AxioMed Viscoelastic Disc Technologies while other firms invested in ball-and-socket articulating spacers.

Share article on social media or email:

Soba Texas Focuses on Individualized and Inpatient Care for Patients To Ensure Recovery


Soba Mesa Texas is an affordable program that provides a luxury setting when treating addiction based in San Antonio, Texas. Soba Texas offers modern, holistic & traditional therapies in order to provide individualized care to each and every Soba client.

At the center of the Soba Texas approach are custom treatments that reinstate that a one size fits all program does not work— everyone deserves a different type of treatment. Soba Mesa’s program is able to customize treatment plans to each client’s unique needs and goals. Soba Mesa Texas measures success by the number of clients who stay clean and sober, as well as by the number of people who enrolled in the program.

One of the most important and overlooked parts of recovery is Inpatient Care. This is one of the main aspects of recovery that Soba Texas focuses on. All the members of this facility will have around the same time sober and will be moving away from a highly structured residential program to a day patient program where important life skills are starting to be introduced. This way patients can leave the facility knowing they can reintegrate back into their lives outside of the facility. This part of recovery is the main factor considered in step three of the Soba Texas recovery plan.

“The Soba Recovery model of treatment focuses on the individual needs of each client that attends our treatment programs. Our full continuum of care provides clients with the tools needed to overcome addiction once and for all,” the website states. Soba Mesa emphasizes sober living as part of the key elements to recovery.

Those suffering or loved ones of people suffering from addiction can fill out a form to further discuss the admission into Soba Recovery on their website here.

About Soba Texas

Soba Mesa is a drug & alcohol treatment program located in San Antonio, Texas that is part of the Soba Recovery network of treatment locations. Soba Mesa offers a full continuum of care from detox to outpatient and sober living, in order to help each client achieve success on the path to long-term recovery. Through our innovative Soba programming, we offer each client a unique treatment experience based on their individual needs in addiction treatment.

Share article on social media or email:

StateView Holds Inaugural MS Golf Tournament September 28th


Eagles Nest Golf Club will play host to the inaugural StateView Homes MS Golf Tournament.

“We all need to stay strong and keep fighting because one day MS will be beat.” – Julian Uccello, Sales and Marketing Specialist at StateView Homes, diagnosed with MS in 2011.

On Wednesday, September 28, 2022, StateView Homes will hold its 1st Annual StateView Homes Golf Tournament at Eagles Nest Golf Club. This event will help raise awareness and funds for research and treatment of Multiple Sclerosis (MS).

MS is the most widespread disabling neurological condition around the world, affecting over 2.3 million people. StateView’s own Julian Uccello, Sales and Marketing Specialist, and brother-in-law to President and CEO Carlo Taurasi and President Dino Taurasi is one of those people who has been diagnosed with this condition.

Diagnosed with MS in 2011, Julian’s blossoming professional soccer career in Europe come to an abrupt end. Since then, Julian’s goal has been to raise money to help find a cure for MS and give back to the MS community. This is a goal that StateView Homes has also undertaken.

Over the past 3 years, StateView Homes has raised over $100,000 for MS research and in support of Mission Stadiums for Multiple Sclerosis (MS4MS) through various events. This tournament is the next step in their commitment to supporting this tremendous cause.

“One thing I have learned is that with MS there are so many unknowns,” said Julian Uccello. He added, “But that’s why we all need to stay strong and keep fighting because one day MS will be beat”.

To learn more about Julian and his journey with MS check out “A Life Long Match” by Metal Monster Productions. For more information on StateView Homes, visit http://www.stateviewhomes.com.

Share article on social media or email:

Outbound AI Launches PayerVA™ Console for Physician Practices and Medical Billing Companies


PayerVA Console™ provides a portfolio of virtual agents and out-of-the-box AI-powered automations for solving tedious claims processing with major commercial and Medicare Advantage health plans. It includes a rapid-training service to quickly automate most of a provider’s payer mix.

Outbound AI, the Conversation AI company for healthcare, today launched PayerVA Console™. The SaaS solution – powered by Outbound AI’s Conversation AI Cloud – simplifies phone-based payer billing work for physician practices and medical billing companies.

PayerVA Console™ provides a portfolio of virtual agents and out-of-the-box AI-powered automations for solving tedious claims processing with major commercial and Medicare Advantage health plans. It includes a rapid-training service to quickly automate most of a provider’s payer mix. Easily integrated into existing systems and workflows, the SaaS solution augments existing workers, improving their productivity while fostering a more enjoyable daily work experience.

PayerVA Console™ helps remove some of the most frustrating parts of a revenue cycle professional’s day – making phone calls to health insurance companies for complex claims. Revenue cycle staff and managers leverage Outbound AI’s Voice AI service to navigate payer IVR systems to autonomously acquire claims information. Outbound’s AI-powered virtual agents can bring a payer representative to a biller, skipping the IVR system navigation and dreaded on-hold monitoring time. Finally, our platform’s transcription capabilities record and document human conversations, eliminating note taking and form entries.

PayerVA Console™ is the first solution built on Outbound AI’s Conversation AI Cloud, an intelligent application platform for healthcare organizations of all sizes that includes enterprise-ready conversational AI technologies, an integrated communications stack, and human-virtual agent teaming software.

“We specifically designed PayerVA Console™ for physician practices and medical billing companies, and with early customers, Outbound has already seen resolution times per task being cut by 30%,” said Stead Burwell, CEO and co-founder of Outbound AI. “As our initial product offering, it demonstrates our commitment to delivering language-based AI solutions that improve not only administrative productivity but also job satisfaction for healthcare workers.”

Outbound AI brings together advanced conversational AI technologies to design and deploy language-models that train AI agents to perform certain tasks that burden healthcare workers each day. The company works closely with a number of strategic industry partners, including global healthcare technology specialist Tegria, and has raised $7M from Madrona Venture Group, Epic Ventures, and strategic healthcare investors and angels.

“Our work with Outbound AI is aligned with Tegria’s goal of bringing distinctive technology to revenue cycle operations,” said Lincoln Popp, Managing Director at Tegria. “PayerVA Console™ is a promising technology that has the potential to address an acute pain point shared by healthcare organizations large and small. We’re excited to continue working closely with Outbound AI and finding new ways to leverage the unique capabilities of their AI platform.”

Outbound AI was founded in 2021 by Stead Burwell, a successful healthcare technology executive, and Jonathan Wiggs, a proven cloud and conversational AI technology leader. Our rapidly growing team of cloud engineers, software developers, and language-based AI experts is on a mission to elevate the human experience in healthcare.

To learn more about Outbound AI and get started with PayerVA Console™, please visit http://www.outbound.ai.

ABOUT OUTBOUND AI

Outbound AI is Conversation AI for healthcare. Our technologies are workforce multipliers that drive productivity while materially improving the daily experience for healthcare workers.

Outbound AI’s enterprise-class Conversation AI Cloud includes enterprise-ready conversational AI technologies, an integrated communications stack, and human-virtual agent teaming software. Leveraging our extensive library of healthcare content and connectors, we can quickly deploy and integrate Outbound AI into any environment, and we play well with legacy healthcare IT infrastructure.

Outbound AI was founded in 2021 by Stead Burwell, a successful healthcare technology executive, and Jonathan Wiggs, a proven cloud and conversational AI technology leader. Together with our rapidly growing team of cloud engineers, software developers, and conversational AI experts, we’re on a mission to elevate the human experience in healthcare.

For more information, visit http://www.outbound.ai.

Share article on social media or email:

StudyKIK to Showcase Suite of Clinical Trial Technologies at the Society for Clinical Research Sites (SCRS) Site Solutions Summit


StudyKIK today announced that the company will be taking part in the Society for Clinical Research Sites (SCRS) Site Solutions Summit, October 7 – 9 in Hollywood, Florida. They will be showcasing their suite of clinical trial technologies at the event that highlights the importance of site sustainability and the impact sites have on clinical research.

StudyKIK will be presenting the Site Patient Recruitment Innovation Award, an award that recognizes sites utilizing innovative strategies to achieve enrollment success. “It’s an honor to both judge and present this year’s Site Patient Recruitment Innovation Award,” said Tarra Shingler, SVP of Global Business Solutions, “at StudyKIK, we recognize the instrumental role sites play in clinical research and we are excited to continue to show our support for the clinical research site community.”

Shingler will also be presenting a breakout session titled “Social Media: Marketing on Facebook, Instagram, Twitter, Tik Tok, and More. A session on patient recruitment and retention”. The presentation will discuss leveraging social media to advance sites goals, different types of social media marketing opportunities that are available to sites and how to use them in partnership with sponsors, CROs and IRBs to present studies and sites in new and creative ways. The session will take place on Saturday, October 8 from 3:00PM – 4:00PM.

About StudyKIK

StudyKIK is the leading provider of clinical trial recruitment and retention technologies for patients, sites, and sponsors. Founded in 2014, StudyKIK has demonstrated improved quality and accelerated enrollment timelines in certain clinical trials by up to 94%. With a mission to make a difference in the world by bringing new treatments to people faster through education and innovative technology, StudyKIK continues to develop new technology-enabled, insight-powered solutions to help support clinical research. For more information visit http://www.studykik.com.

Share article on social media or email:

MDsave and West Jefferson Medical Center Develop Partnership


News Image

MDsave, the nation’s leading online medical service marketplace connecting providers, employers and consumers to affordable and accessible healthcare announces a new partnership with West Jefferson Medical Center. This partnership is part of the ongoing expansion of MDsave’s efforts to bring affordable, quality healthcare to the communities of New Orleans.

With a proven track record of more than 60 years of service to the Westbank of Jefferson Parish and the surrounding area, West Jefferson Medical Center (West Jefferson) is well respected regionally and nationally for excellence in patient care, distinguishing it from other hospitals in the greater New Orleans area. This partnership with MDsave opens the door to new patients by offering cash prices to those with high deductibles or who have no insurance.

“We are excited about this partnership in the greater New Orleans area knowing we share a similar mission of providing quality care in a comforting and cost-effective manner,” says Paul Ketchel, chief executive officer of MDsave. “We believe with each new partnership we help bridge the gap between patients who need specialized healthcare and those who deliver high quality care without the confusion and stress normally associated with procedures requiring multiple providers and facilities.”

The MDsave Marketplace allows hospitals to bundle medical services and offer them directly to patients as a single price paid pre-service. MDsave also connects employers to local hospitals and health systems building volume and loyalty in the local community through an innovative digital platform.

“We are proud to partner with MDSave to help simplify the healthcare billing process for our Westbank patients and providers, says Rob Calhoun, president and chief executive officer of West Jefferson Medical Center.” As another important step to provide patient-centered care, we’re bringing a new a level of transparency and affordable pricing directly to the patients who need it most.”

About MDSave

Headquartered in Nashville, TN, MDsave is the nation’s leading online medical service marketplace connecting providers, employers and consumers connecting to affordable, reliable high-quality healthcare at fair, transparent prices. Through innovative technology, MDsave simplifies the healthcare billing process for patients and providers through bundled pricing and upfront payment. MDsave’s patented technology also supports employers and payers to deliver more value to employees and policyholders minimizing out-of-pocket deductible costs. For more information, visit http://www.mdsave.com.

About West Jefferson Medical Center

Founded in 1956, West Jefferson Medical Center (West Jefferson) is a 419-bed community hospital located in Marrero, La. As a full-service medical center, West Jefferson offers comprehensive programs for preventive, emergency, acute and rehabilitative care with a medical staff of more than 450 physicians and a complement of 1,700 employees and many volunteers. The medical center enjoys national awards for clinical excellence across many of its subspecialties.

West Jefferson is a proud member of LCMC Health, a Louisiana-based, not-for-profit hospital system serving the healthcare needs of the Gulf Coast region. LCMC Health currently manages award-winning community hospitals including Children’s Hospital, Touro, New Orleans East Hospital, University Medical Center New Orleans, East Jefferson General Hospital and West Jefferson Medical Center. For more information, visit: https://www.lcmchealth.org/west-jefferson-medical-center/.

Share article on social media or email:

PPE Supply Canada Has Donated 100,000 Masks With More To Share


PPE Supply Canada has donated 100,000 NIOSH-approved respirators since the spring of 2022. After working with non-profit clients throughout the pandemic, the company gained an understanding of how much demand there is for personal protective equipment among the vulnerable. They soon developed a monthly donation program, where they donate a range between 10,000 and 25,000 NIOSH-certified respirators, depending on how many the client is able to receive.

“It’s been a tumultuous few years and we’ve seen how hard the pandemic has hit our vulnerable and compromised communities. Even though we’re stepping out of it now, there are many that are still recovering from the harsh effects,” says Hussein Dhalla, founder and owner of PPE Supply Canada. “Our mission has always been to help others and keep our country well protected. Everyone has the right to feel safe and we want to do our part in contributing to the stability of our communities. Our sincerest thanks go to frontline workers and those who represent these non-profit organizations, as they’re the ones making the most impact. We just want to provide them with even more flexibility to be there for those in need,” he adds.

PPE Supply Canada has aligned with a diverse range of organizations over the past few months, ranging from charities that assist those with immunodeficiencies to others that aid in global disaster relief, such as the crisis in Ukraine, and more. These include Canadian Immunodeficiencies Patient Organization, Sherbourne Health, Global Medic and LOFT Community Services. They will continue to partner with inspirational organizations that share the same values and will get their masks into the right hands, at the right time.

If you’re a charitable organization in need of N95 respirators, please connect with PPE Supply Canada at 647-577-2624 or contact@ppe-supply.com

About PPE Supply Canada:

PPE Supply Canada is a Toronto-based personal protective equipment retailer. Focusing on the needs of its communities, the company strives to provide exceptional experiences alongside high-quality personal protective equipment that has been trusted by its diverse customer base throughout the COVID-19 pandemic. All of their orders are shipped out the same business day they are placed and they provide priority shipping from coast to coast. Same-day delivery within the Greater Toronto Area is available if the order is submitted before 11:00 AM EST. The company has also partnered with Uber Eats Canada, making its items readily available to local consumers. PPE Supply Canada is equipped with a team that handles the needs and requests of all B2B clients, ensuring extraordinary customer service, fast shipping times and happy customers. PPE Supply Canada is Registered with Health Canada and holds its Health Canada Medical Device Establishment License (MDEL) which permits the company to manufacture, distribute and import medical devices in Canada. Visit their store at http://www.ppe-supply.com.

Media Contact

Company Name: PPE Supply Canada

Contact Person: Mackenzie Smith

Phone: 647-577-2624

Website: http://www.ppe-supply.com

Share article on social media or email:

G-CON Manufacturing Announces Hiring of Chief Financial Officer


We are very happy to welcome Sanjay to our team.

G-CON, the producer of off-site prefabricated cleanroom solutions, announced today that it has appointed Sanjay Jajoo to serve as Chief Financial Officer. Sanjay joins G-CON with 20+ years of financial experience in manufacturing firms across the industrials space including chemicals (polymers), energy and power, oil and gas, and water infrastructure, in both the public and private sectors.

“We are very happy to welcome Sanjay to our team,” said Maik Jornitz, President and CEO of G-CON Manufacturing. “His financial acumen, planning and management skills along with his experience in manufacturing operations will be valuable for our stakeholders as we continue our growth.”

Jajoo will lead G-CON’s financial and accounting team. He will report to G-CON’s President and CEO, Maik Jornitz.

Mr. Jajoo previously served as Director of Global Finance and Corporate Strategy roles – Kraton Polymers and has held leadership roles across power, energy infrastructure, and oil & gas teams at General Electric. He has served on the board of directors for HGH, a community non-profit organization in Houston. Along with CPA he also holds a bachelor’s from the University of Mumbai and Chartered Accountancy (CA) from the Institute of Chartered Accountants, India.

About G-CON

G-CON builds PODular cleanrooms offsite for innovative biopharmaceutical & pharmaceutical companies. Streamlined, offsite building processes enable G-CON to deliver the highest quality cleanroom facilities, quickly and on time. G-CON adapts to unique requirements on every build, delivering projects with our commitment to certainty every time.

Share article on social media or email:

Torrance Memorial Medical Center first in nation to receive Leading Laboratories recognition from ASCP and The Joint Commission


News Image

“The Leading Laboratories recognition elevates and distinguishes the discerning and empowering work laboratories do for patients every day,” said E. Blair Holladay, PhD, MASCP, SCT(ASCP)CM, CEO of ASCP.

Torrance Memorial Medical Center today announced it is the first in the nation to receive the Leading Laboratories recognition from the American Society for Clinical Pathology (ASCP) and The Joint Commission. The two-year designation serves as proof of Torrance Memorial’s commitment to laboratory excellence and to help improve patient outcomes.

Torrance Memorial underwent a rigorous application process to receive the recognition, including a review of its outcomes, indicators, metrics and evidence. Additionally, it had to demonstrate excellence in four key areas: elevating quality outcomes, supporting professional development, cultivating trusted leadership and promoting laboratory visibility.

With focus on building a high-quality, state-of-the-art laboratory, the Torrance Memorial Department of Pathology and Clinical Laboratory (DPCL) initiated a five-year strategic plan based on six key pillars: people and culture, quality, financials, innovation, education, and growth. In 2021, DPCL implemented a robust quality management program. The quality program helped define, establish and maintain a collaborative, systematic and organization-wide approach to quality management.

Additional initiatives have included implementing core lab automation to reduce the outsourcing of select tests, increasing volume of outreach business, reducing turn-around-time, and improving efficiency and productivity. Through a newly produced quarterly newsletter, the DPCL expanded engagement and increased visibility of these new innovations.

Central to the growth of the DPCL was the need to develop high-performing teams. In addition to supporting career development, lab leadership engaged in regular rounding to foster a motivating work climate – recognizing and rewarding outstanding team and individual contributions.

“It is an honor to be the first in the nation to receive the Leading Laboratories recognition. This designation reflects the commitment to excellence by every member of the Torrance Memorial Pathology and Clinical Laboratory,” said Keith Hobbs, executive vice president, Torrance Memorial Medical Center.

“The Leading Laboratories recognition elevates and distinguishes the discerning and empowering work laboratories do for patients every day,” said E. Blair Holladay, PhD, MASCP, SCT(ASCP)CM, CEO of ASCP. “We congratulate Torrance Memorial Medical Center on its dedication to patient care, and its commitment to raising the visibility of the laboratory as the foundation of healthcare.”

“We congratulate Torrance Memorial Medical Center on being the first in the nation to receive the Leading Laboratories recognition,” said Heather Hurley, executive director, Laboratory Accreditation, The Joint Commission. “As the first hospital laboratory to receive this designation, Torrance Memorial is demonstrating its commitment to laboratory staff through professional development and trusted leadership. It also is promoting laboratory visibility, including the complex work of laboratory staff to provide the continuum of care, to its organization, patients and community.”

The Leading Laboratories recognition, developed and refined by laboratory leaders, is available to all Joint Commission-accredited hospital laboratories. To learn more about the program, please visit leadinglaboratories.org.

###

About Torrance Memorial Medical Center

Founded in 1925 by Jared Sidney and Helena Childs Torrance, Torrance Memorial Medical Center is a 443-bed, nonprofit medical center established to provide quality health care services predominantly to the residents of the South Bay, Peninsula and Harbor communities. Torrance Memorial seeks to offer the most current and effective medical technologies rendered in a compassionate, caring manner. No longer just a hospital, today Torrance Memorial Medical Center includes an extensive integrated system of physicians and comprehensive medical services to provide coordinated communication and continuum of care. Torrance Memorial is affiliated with Cedars-Sinai under the umbrella of Cedars-Sinai Health System. Torrance Memorial’s nursing program has earned coveted Magnet® recognition from the American Nurses Credentialing Center, which recognizes nursing excellence. Torrance Memorial Medical Center has once again been recognized as a Best Hospital for 2022-23 for the eleventh straight year by U.S. News & World Report, placing the hospital in the top 3% in the state. Torrance Memorial is the 11th highest ranking hospital for overall hospital quality in the state of California and 5th in the Los Angeles region.

For more information, please visit: http://www.TorranceMemorial.org.

About ASCP

Founded in 1922, the American Society for Clinical Pathology unites more than 100,000 anatomic and clinical pathologists, medical laboratory professionals, residents, and students to accelerate the advancement of pathology and laboratory medicine to better improve patient care through knowledge, collaboration, and global community. To learn more, visit http://www.ascp.org/content/home.

About The Joint Commission

Founded in 1951, The Joint Commission seeks to continuously improve healthcare for the public, in collaboration with other stakeholders, by evaluating healthcare organizations and inspiring them to excel in providing safe and effective care of the highest quality and value. The Joint Commission accredits and certifies more than 22,000 healthcare organizations and programs in the United States. An independent, nonprofit organization, The Joint Commission is the nation’s oldest and largest standards-setting and accrediting body in healthcare. Learn more about The Joint Commission at http://www.jointcommission.org.

Share article on social media or email: